对乙酰氨基酚诱导的肝衰竭预后最差的患者早期存在单核细胞减少
在苏格兰肝移植单元开展的前瞻性病例对照研究纳入35例对乙酰氨基酚诱导肝衰竭(POD-ALF)患者、10例非对乙酰氨基酚所致ALF患者和16例对照,分析外周血单核细胞表型、细胞因子和单核细胞基因表达与结局的关系。POD-ALF预后最差者入院时存在显著单核细胞减少(经典和中间型单核细胞减少),伴淋巴细胞和自然杀伤细胞减少及提示「细胞因子风暴」的细胞因子模式;非对乙酰氨基酚ALF患者未见此现象。
要点
- POD-ALF预后最差者入院时存在显著单核细胞减少,以经典和中间型单核细胞减少为特征。
- 该单核细胞减少伴循环淋巴细胞和自然杀伤细胞减少及提示「细胞因子风暴」的细胞因子模式。
- 第4天存活者与不良结局者之间单核细胞、淋巴细胞或自然杀伤细胞无显著差异。
核心结论
- 严重对乙酰氨基酚肝衰竭与外周血尤其单核细胞的深刻变化相关,并与更差结局相关;非对乙酰氨基酚诱导的肝衰竭患者未见此现象。
- 入院时显著单核细胞减少可能有助于更早明确预后,并提示潜在的治疗干预靶点。
研究设计与样本
- 前瞻性病例对照研究,在苏格兰肝移植单元、爱丁堡皇家医院(Royal Infirmary Edinburgh)开展。
- 纳入35例连续入院的对乙酰氨基酚诱导肝衰竭(POD-ALF)患者、10例非对乙酰氨基酚所致ALF患者和16例对照。
- 采用流式细胞术分析外周血单核细胞表型,蛋白阵列定量循环细胞因子,并行单核细胞基因表达阵列,与结局关联。
主要发现
- 入院时POD-ALF预后最差者存在显著单核细胞减少,以经典和中间型单核细胞群体减少为特征。
- 该单核细胞减少与循环淋巴细胞和自然杀伤细胞减少、提示「细胞因子风暴」的外周细胞因子模式及与单核细胞自骨髓动员相关的细胞因子浓度升高相关。
- 基因表达阵列未能区分患者结局。
- 第4天,存活者与不良结局患者之间单核细胞、淋巴细胞或自然杀伤细胞无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute liver failure (ALF) is associated with significant morbidity and mortality. Studies have implicated the immune response, especially monocyte/macrophages as being important in dictating outcome. AIM: To investigate changes in the circulating monocytes and other immune cells serially in patients with ALF, relate these with cytokine concentrations, monocyte gene expression and patient outcome. METHODS: In a prospective case-control study in the Scottish Liver Transplant Unit, Royal Infirmary Edinburgh, 35 consecutive patients admitted with paracetamol-induced liver failure (POD-ALF), 10 patients with non-paracetamol causes of ALF and 16 controls were recruited. The peripheral blood monocyte phenotype was analysed by flow cytometry, circulating cytokines quantified by protein array and monocyte gene expression array performed and related to outcome. RESULTS: On admission, patients with worst outcomes after POD-ALF had a significant monocytopenia, characterised by reduced classical and expanded intermediate monocyte population. This was associated with reduced circulating lymphocytes and natural killer cells, peripheral cytokine patterns suggestive of a 'cytokine storm' and increased concentrations of cytokines associated with monocyte egress from the bone marrow. Gene expression array did not differentiate patient outcome. At day 4, there was no significant difference in monocyte, lymphocyte or natural killer cells between survivors and the patients with adverse outcomes. CONCLUSIONS: Severe paracetamol liver failure is associated with profound changes in the peripheral blood compartment, particularly in monocytes, related with worse outcomes. This is not seen in patients with non-paracetamol-induced liver failure. Significant monocytopenia on admission may allow earlier clarification of prognosis, and it highlights a potential target for therapeutic intervention.
引用
- Moore JK, MacKinnon AC, Man TY, et al. Patients with the worst outcomes after paracetamol (acetaminophen)-induced liver failure have an early monocytopenia. Aliment Pharmacol Ther. 2016. PMID: 27896824. doi:10.1111/apt.13878
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。